Cargando…

Adherence to Antiretroviral Treatment Among People Who Started Treatment on the Same-Day of HIV Diagnosis in Ethiopia: A Multicenter Observational Study

INTRODUCTION: Since the launch of universal “test and treat” approach in 2016, there has been a significant increase in persons initiated on antiretroviral therapy (ART) on the same-day of human immunodeficiency virus (HIV) diagnosis in low-income settings. However, there are limited studies that in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Ismael, Demissie, Meaza, Worku, Alemayehu, Gugsa, Salem, Berhane, Yemane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590980/
https://www.ncbi.nlm.nih.gov/pubmed/34785956
http://dx.doi.org/10.2147/HIV.S337073
_version_ 1784599110091800576
author Ahmed, Ismael
Demissie, Meaza
Worku, Alemayehu
Gugsa, Salem
Berhane, Yemane
author_facet Ahmed, Ismael
Demissie, Meaza
Worku, Alemayehu
Gugsa, Salem
Berhane, Yemane
author_sort Ahmed, Ismael
collection PubMed
description INTRODUCTION: Since the launch of universal “test and treat” approach in 2016, there has been a significant increase in persons initiated on antiretroviral therapy (ART) on the same-day of human immunodeficiency virus (HIV) diagnosis in low-income settings. However, there are limited studies that investigated the effect of rapid treatment initiation on adherence. In this study, we compared adherence to ART in people who started ART on the same-day of HIV diagnosis and those started more than 7 days after HIV diagnosis. METHODS: We conducted a retrospective cohort analysis using routinely collected data from multiple ART clinics. Participants were at least 15 years old, were newly diagnosed and started on ART between October 2016 and July 2018 in the Amhara region of Ethiopia. We used doubly-robust multivariable logistic regression model to estimate the adjusted effects on adherence. RESULTS: A total of 415 individuals who started ART on the same-day of HIV diagnosis and 527 individuals who started 7 days after their HIV diagnosis were included in the analysis. The proportion of participants who reported optimal adherence was significantly lower in the same-day group at 6- and 12-months (absolute risk difference of 6.5%; 95% CI: 1.1%, 11.9% and 6.8%; 95% CI: 1.2%, 12.5%, respectively) compared to the >7 days group. After adjusting for baseline and non-baseline covariates, the same-day group was less likely to have optimal adherence both at 6- and 12-months (adjusted RR=0.90; 95% CI: 0.86, 0.94 and RR=0.89; 95% CI: 0.83, 0.95, respectively) compared to the >7 days group. CONCLUSION: We observed lower optimal adherence among individuals who started ART on the same-day of HIV diagnosis compared to those who started ART >7 days after their HIV diagnosis. Our findings highlight the importance of identifying adherence barriers, providing support, and ensuring treatment readiness before initiating individuals on same-day ART.
format Online
Article
Text
id pubmed-8590980
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85909802021-11-15 Adherence to Antiretroviral Treatment Among People Who Started Treatment on the Same-Day of HIV Diagnosis in Ethiopia: A Multicenter Observational Study Ahmed, Ismael Demissie, Meaza Worku, Alemayehu Gugsa, Salem Berhane, Yemane HIV AIDS (Auckl) Original Research INTRODUCTION: Since the launch of universal “test and treat” approach in 2016, there has been a significant increase in persons initiated on antiretroviral therapy (ART) on the same-day of human immunodeficiency virus (HIV) diagnosis in low-income settings. However, there are limited studies that investigated the effect of rapid treatment initiation on adherence. In this study, we compared adherence to ART in people who started ART on the same-day of HIV diagnosis and those started more than 7 days after HIV diagnosis. METHODS: We conducted a retrospective cohort analysis using routinely collected data from multiple ART clinics. Participants were at least 15 years old, were newly diagnosed and started on ART between October 2016 and July 2018 in the Amhara region of Ethiopia. We used doubly-robust multivariable logistic regression model to estimate the adjusted effects on adherence. RESULTS: A total of 415 individuals who started ART on the same-day of HIV diagnosis and 527 individuals who started 7 days after their HIV diagnosis were included in the analysis. The proportion of participants who reported optimal adherence was significantly lower in the same-day group at 6- and 12-months (absolute risk difference of 6.5%; 95% CI: 1.1%, 11.9% and 6.8%; 95% CI: 1.2%, 12.5%, respectively) compared to the >7 days group. After adjusting for baseline and non-baseline covariates, the same-day group was less likely to have optimal adherence both at 6- and 12-months (adjusted RR=0.90; 95% CI: 0.86, 0.94 and RR=0.89; 95% CI: 0.83, 0.95, respectively) compared to the >7 days group. CONCLUSION: We observed lower optimal adherence among individuals who started ART on the same-day of HIV diagnosis compared to those who started ART >7 days after their HIV diagnosis. Our findings highlight the importance of identifying adherence barriers, providing support, and ensuring treatment readiness before initiating individuals on same-day ART. Dove 2021-11-10 /pmc/articles/PMC8590980/ /pubmed/34785956 http://dx.doi.org/10.2147/HIV.S337073 Text en © 2021 Ahmed et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ahmed, Ismael
Demissie, Meaza
Worku, Alemayehu
Gugsa, Salem
Berhane, Yemane
Adherence to Antiretroviral Treatment Among People Who Started Treatment on the Same-Day of HIV Diagnosis in Ethiopia: A Multicenter Observational Study
title Adherence to Antiretroviral Treatment Among People Who Started Treatment on the Same-Day of HIV Diagnosis in Ethiopia: A Multicenter Observational Study
title_full Adherence to Antiretroviral Treatment Among People Who Started Treatment on the Same-Day of HIV Diagnosis in Ethiopia: A Multicenter Observational Study
title_fullStr Adherence to Antiretroviral Treatment Among People Who Started Treatment on the Same-Day of HIV Diagnosis in Ethiopia: A Multicenter Observational Study
title_full_unstemmed Adherence to Antiretroviral Treatment Among People Who Started Treatment on the Same-Day of HIV Diagnosis in Ethiopia: A Multicenter Observational Study
title_short Adherence to Antiretroviral Treatment Among People Who Started Treatment on the Same-Day of HIV Diagnosis in Ethiopia: A Multicenter Observational Study
title_sort adherence to antiretroviral treatment among people who started treatment on the same-day of hiv diagnosis in ethiopia: a multicenter observational study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590980/
https://www.ncbi.nlm.nih.gov/pubmed/34785956
http://dx.doi.org/10.2147/HIV.S337073
work_keys_str_mv AT ahmedismael adherencetoantiretroviraltreatmentamongpeoplewhostartedtreatmentonthesamedayofhivdiagnosisinethiopiaamulticenterobservationalstudy
AT demissiemeaza adherencetoantiretroviraltreatmentamongpeoplewhostartedtreatmentonthesamedayofhivdiagnosisinethiopiaamulticenterobservationalstudy
AT workualemayehu adherencetoantiretroviraltreatmentamongpeoplewhostartedtreatmentonthesamedayofhivdiagnosisinethiopiaamulticenterobservationalstudy
AT gugsasalem adherencetoantiretroviraltreatmentamongpeoplewhostartedtreatmentonthesamedayofhivdiagnosisinethiopiaamulticenterobservationalstudy
AT berhaneyemane adherencetoantiretroviraltreatmentamongpeoplewhostartedtreatmentonthesamedayofhivdiagnosisinethiopiaamulticenterobservationalstudy